Saint-Herblain (France), November 7, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-

3 Blue-Chip Stocks With Strong Dividends

07:20pm, Monday, 06'th Nov 2023
As an investor, you need an edge to outperform the market. However, as you reach for performance, you should be cognizant of the risks in the current macro environment.
Kristopher Koeller relies on two daily medications to keep his blood pressure under control. They're both generics that have been on the market for decades–the kind of drugs that should be cheap.
On October 25 2023 an on-line edition of Fortune Magazine revealed 100 Fastest Growing Public Companies. My Dogcatcher quest to sniff-out dividend-buys found 57 dividend-paying fast-growers using YCha
AbbVie should be poised to return to rapid growth and recently boosted its dividend. Novartis' spin-off of Sandoz doesn't diminish its attractiveness for income investors.
A mix of trepidation and optimism permeate the fluctuating U.S. stock market landscape at this time. Consequently, the hunt for stocks to buy for under $100 becomes more of a strategic endeavor.
High dividend yield companies are valuable assets for your portfolio, since they are a great way to generate added income, which you can reinvest or use it to pay your bills. In today's article, I wil
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr

Should You Pick Pfizer Stock At $30?

09:00am, Friday, 03'rd Nov 2023
Pfizer (NYSE: PFE) reported its Q3 results earlier this week, with revenues missing but earnings beating the street estimates, and we believe that PFE stock has ample
With the major equity indices signaling the possibility of a slowdown – if not an outright downcycle – investors may be better served considering overlooked value stocks. At this moment, I like th
Pfizer reported an adjusted loss of nearly $1 billion in the third quarter, and recently lowered its forecasts for coronavirus product sales. The company also faces potential sales declines in other b
Investors who want to beat the market must consider growth stocks. You have to be aggressive to capture higher returns.
In 2023, the broader market has ignored the deep value proposition of most large-cap pharmaceutical stocks. Pfizer, a stalwart of the industry, has been among the group's worst performers this year.
The healthcare sector has produced several of the best-performing stocks since World War II. The secret to their outperformance has been their laser-like focus on innovation.

7 Dividend Stocks That Are a Recipe for Disaster

10:09am, Wednesday, 01'st Nov 2023
Following the rise in interest rates, many stocks, including shares in large, well-known companies, now sport relatively high dividend yields. Yet before you decide to buy, beware of the names best le
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE